Project Grant R44DA053845

Award Date 7/15/22
Completion Date 1/31/26
Dollars Obligated $5.6M
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This Project Grant award of $355,414 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to implement and evaluate the use of a digital therapeutic, Computer-Based Training for Cognitive Behavioral Therapy (CBT4CBT), to address substance use disorders (SUDs), including opioid use disorder (OUD), among incarcerated individuals. The award supports a research plan with two key components: 1) Qualitative interviews with addiction...
This $1,338,750 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and pilot testing of a brief, digitally-enhanced intervention called IMPROVE to reduce heavy alcohol use among individuals receiving medication for opioid use disorder (MOUD). The project aims to adapt the IMPROVE intervention to address anxiety sensitivity and intolerance of uncertainty - two key risk factors for...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will pilot an innovative digital Contingency Management (CM) treatment delivered via mobile device to Medicaid beneficiaries with co-occurring opioid and alcohol use disorders. The $390,000 award, spanning from September 2024 to August 2027, aims to: 1) identify optimal approaches to engage Medicaid beneficiaries in digital CM through Medicaid claims data...
This $385,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to advance integrated treatment for co-occurring opioid use disorder (OUD) and alcohol use disorder (AUD) in real-world settings. The key objectives are to: Assess the effectiveness of integrated treatment approaches, including first-line medications and glucagon-like peptide-1 receptor agonists (GLP-1 RAs), for patients with co-occurring OUD...
This federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) totaling $945,397 provides funding to the Magee-Womens Research Institute and Foundation, with a sub-award to the University of Pittsburgh, to adapt and evaluate a collaborative care model (CCM) for treating pregnant persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt the CCM for rural and low-resource...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $326,410 to Berkshire Biomedical Corporation to conduct a two-phased clinical study on the use of a hand-held, automated, personalized oral liquid dispensing system called COPATM for take-home methadone medication management for patients with opioid use disorder (OUD). The Phase I feasibility study will evaluate the functionality and acceptance...
This Project Grant award, with a total funding amount of $958,629, was awarded by the National Institute on Drug Abuse (NIDA) under the Drug Abuse and Addiction Research Programs (CFDA 93.279). The funding will support the real-world adoption of an innovative digital health therapeutic called KIOS, which uses nonlinear control theory to track multiple symptoms (e.g., craving, mood, pain) and deliver personalized, evidence-based intervention strategies to patients with opioid use disorder...
This $2,729,018 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support the development and evaluation of a mobile health intervention for individuals with co-occurring opioid use disorder (OUD) and post-traumatic stress disorder (PTSD) during community re-entry after residential OUD treatment. The proposed study will use a ground-up, user-centered approach to rigorously develop and evaluate a mobile app...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $844,475 to the University of Alabama at Birmingham (UAB) to test a bundled intervention aimed at increasing treatment uptake for patients with opioid use disorder (OUD) and nonfatal opioid overdoses after emergency department (ED) discharge. The proposed intervention combines telehealth, peer support, buprenorphine prescribing, and linkage to...
The National Institute on Drug Abuse (NIDA) awarded a $1,076,018 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Dynamicare Health Inc. in Wareham, MA. The award will fund a Phase II randomized clinical trial to evaluate the efficacy of DCH-003, a digital therapeutic that delivers contingency management for the treatment of stimulant use disorder. The trial will compare standard clinic care plus DCH-003 to standard care plus a sham digital app, with the...

FAST-TRACK: SCALABLE DIGITAL DELIVERY OF EVIDENCE-BASED TRAINING FOR ADDICTION PROFESSIONALS TO MAXIMIZE TREATMENT ADMISSION AND RETENTION RATES OF OPIOID USE DISORDER IN AFFECTED FAMILIES. - EFFECTIVE MEDICATION-BASED TREATMENT COULD PREVENT OVERDOSE DEATHS AND HELP OVER 2 MILLION AMERICANS RECOVER FROM OPIOID USE DISORDER (OUD), BUT ONLY A FRACTION ACCESS SPECIALTY TREATMENT OR RECEIVE AN FDA-APPROVED MEDICATION. COMMUNITY REINFORCEMENT AND FAMILY TRAINING (CRAFT) WORKS WITH FAMILY MEMBERS TO GET TREATMENT RESISTANT INDIVIDUALS (IDENTIFIED PERSONS; IPS) INTO TREATMENT, AND 68% OF FAMILIES COACHED IN CRAFT ACHIEVE TREATMENT ENTRY FOR THEIR IP; ABOUT TWICE AS MANY AS COMPARISON GROUPS. HOWEVER, MOST ADDICTION PROFESSIONALS (COUNSELORS) ARE NOT TRAINED IN CRAFT OR DELIVER IT WITH QUESTIONABLE FIDELITY. THE GOAL OF THIS PROJECT IS TO DEVELOP AND EVALUATE THE TECHNICAL FEASIBILITY AND COMMERCIAL VIABILITY OF A SCALABLE DIGITAL COUNSELOR TRAINING PROGRAM FOR CRAFT. THE COUNSELOR PRODUCT WOULD BE TAILORED TO PREPARE COUNSELORS TO WORK WITH FAMILY MEMBERS OF INDIVIDUALS WITH OUD. IT WILL ALLOW COUNSELORS TO DELIVER HIGH-FIDELITY CRAFT AND SIGNIFICANTLY BENEFIT IPS AND THEIR FAMILIES AFFECTED BY OUD BY ADDRESSING THE CRITICAL BARRIER OF ACCESS TO A LEADING EVIDENCE-BASED APPROACH TO FAMILY INVOLVEMENT IN ADDICTION RECOVERY. CURRENT METHODS FOR TRAINING COUNSELORS AND DISSEMINATING ESTS, INCLUDING CRAFT, RELY ON BRIEF ONLINE OR IN-PERSON WORKSHOPS. HOWEVER, RESEARCH SHOWS THIS FORMAT IS MINIMALLY EFFECTIVE IN FACILITATING ADOPTION AND IMPLEMENTATION OF ESTS. A MORE EFFICACIOUS MODEL INCLUDES ONGOING COUNSELOR TRAINING WITH FEEDBACK AND COACHING. THIS PROJECT WILL DEVELOP AN ENHANCED TRAINING MODEL FOR CRAFT AND DIGITIZE IT TO MAXIMIZE SCALABILITY. IN THIS PROJECT, WE WILL: PRODUCE THE DIGITAL COUNSELOR TRAINING PROTOTYPE AND COACHING PROCESS, TAILORED TO OUD - WITH STAKEHOLDER INPUT (AIM 1); CONDUCT A PILOT STUDY OF 3 LEVELS OF DIGITAL TRAINING (LEVEL 1 -DIGITAL TUTORIAL ONLY [T]; LEVEL 2 -TUTORIAL & DIGITAL TRAINING MATERIALS FOR SELF-STUDY [TM]; LEVEL 3 - TUTORIAL, DIGITAL MATERIALS, FEEDBACK AND COACHING [TMC]) TO ESTABLISH FEASIBILITY, ACCEPTABILITY, AND EXAMINE THE EFFECTS OF TRAINING ON CRAFT KNOWLEDGE, FIDELITY, AND TREATMENT ENTRY AND RETENTION (AIM 2). VALIDATION OF FEASIBILITY AND COMMERCIAL MERIT IN THE PHASE I PILOT STUDY WILL PROVIDE SUBSTANTIATION TO ADVANCE TO PHASE II. IN ADDITION TO OPTIMIZING THE PRODUCT BASED ON PHASE I LEARNINGS AND STAKEHOLDER INPUT, PHASE II GOALS WILL INCLUDE COMPLETING DEVELOPMENT OF A SUPERVISED MACHINE LEARNING (SML) AUTOMATED CODING SYSTEM THAT WILL SCORE COUNSELOR-SUBMITTED DIGITAL AUDIOTAPES OF CRAFT SESSIONS AND GENERATE WRITTEN FEEDBACK INCLUDING SUGGESTIONS FOR IMPROVEMENT. THIS WILL ALLOW US TO DEMONSTRATE DIGITAL TRAINING EFFICACY AT SCALE AND COMMERCIAL READINESS (AIM 3). WE WILL CONDUCT A FULLY-POWERED RANDOMIZED CONTROL TRIAL COMPARING ALL PILOTED OUTCOMES FOR THE 3 TRAINING LEVEL CONDITIONS (AIM 4). THESE STUDIES FORM THE BASIS TO DEMONSTRATE COMMERCIAL READINESS AND VALUE TO PURCHASERS.

Posted 7/14/22, 12:00 AM